Incannex Healthcare Inc. (IXHL) stock
IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.86+0.12 (+6.90%)
Close on Nov 20, 2026Market cap $23.33MP/E –Yield –
Incannex Healthcare free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Incannex Healthcare's free cash flow for the twelve months ending Sep 30, 2026 was -$3.19M. For fiscal 2026 it was -$12.88M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$12.88M | – |
| FY2025 | Jun 30, 2025 | -$12.52M | – |
| FY2024 | Jun 30, 2024 | -$16.12M | – |
| FY2023 | Jun 30, 2023 | -$11.07M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $521.00K | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $3.38M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$2.46M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$4.63M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$9.17M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$1.48M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$3.16M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$3.65M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$4.35M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$2.16M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$5.97M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$2.75M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$2.76M | – |
See a number that looks wrong?